Wall Street registered the best week of the year for major indexes.

President Biden and the DOJ have officially announced the rescheduling of cannabis to Schedule III, sparking increased activity in cannabis stocks. The MJUS ETF focuses on US-based cannabis firms and ...

Digging into the first quarter's earnings season allows us to uncover the winning themes of the period as captured by ETFs.

Amplify Alternative Harvest ETF offers diversified investments in Canadian cannabis stocks and U.S. multi-state operators. Catalysts such as a reduction in the Canadian excise tax, potential legalizat...

As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipien...

Cannabis stocks soared this year after the Department of Health and Human Services asked the US Drug Enforcement Administration to start reviewing its classification of cannabis from Schedule I to Sch...

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Ac...

Wall Street wrapped up last week on a positive note, thanks to a combination of strong earnings reports from major tech companies and a better-than-expected jobs report.

January proved to be a month of fluctuation for Wall Street. While concerns about reduced expectations for rate cuts had an adverse impact, the stock market saw a rally thanks to strong corporate earn...

The cannabis industry has been performing well this year after the US Drug Enforcement Administration started reviewing the potential reclassification of cannabis from Schedule I to Schedule III.

Both the S&P 500 and Dow Jones are hitting a series of new highs lately driven by strong corporate earnings, governmental policy moves and investor confidence in the tech sector and AI developments.

Marijuana stocks spiked following the report that the US Drug Enforcement Administration (DEA) is reviewing the potential reclassification of cannabis from Schedule I to Schedule III.

The ETFMG U.S. Alternative Harvest ETF focuses on stocks in the cannabis business, pharmaceuticals, biotechnology, and life sciences sectors. The ETF has never paid a dividend and has a high concentra...